Plant ID: NPO24893
Plant Latin Name: Polyalthia nemoralis
Taxonomy Genus: Polyalthia
Taxonomy Family: Annonaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TSHR; NPSR1; | |
TDP1; ALOX15; ALDH1A1; USP2; | |
CA12; CA1; CA5A; CA5B; CA6; | |
PPARA; PPARD; | |
KDM4E; | |
TLR2; | |
HIF1A; TP53; | |
HTT; LMNA; FABP3; FABP5; FABP2; FABP4; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.740E-12 | 1.903E-07 | CA1, CA12, CA5A, CA5B, CA6 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.077E-09 | 7.814E-06 | CA1, CA12, CA5A, CA5B, CA6 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 3.079E-09 | 1.676E-05 | CA1, CA12, CA5A, CA5B, CA6 |
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 3.200E-08 | 9.953E-05 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 3.264E-06 | 2.843E-03 | ALOX15, PPARA, PPARD, TP53 |
BP | GO:0008152; metabolic process | GO:0009299; mRNA transcription | 4.882E-06 | 3.938E-03 | HIF1A, PPARD, TP53 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 7.563E-06 | 5.147E-03 | CA1, CA12, CA5A, CA5B, CA6, PPARA, PPARD, TP53 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 1.082E-05 | 6.733E-03 | HIF1A, LMNA, PPARD, TP53 |
MF | GO:0005488; binding | GO:0097371; MDM2/MDM4 family protein binding | 3.644E-05 | 1.889E-02 | PPARA, TP53 |
MF | GO:0005488; binding | GO:0036041; long-chain fatty acid binding | 9.511E-05 | 4.142E-02 | FABP3, PPARD |
MF | GO:0005488; binding | GO:0002039; p53 binding | 1.116E-04 | 4.674E-02 | HIF1A, HTT, TP53 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 1.140E-04 | 4.685E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.511E-11 | 1.194E-09 | CA12, CA1, CA5B, CA5A, CA6 |
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 2.944E-10 | 1.163E-08 | FABP2, FABP3, FABP4, FABP5, PPARA, PPARD |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 6.457E-04 | 1.700E-02 | ALOX15, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05205 | Proteoglycans in cancer | 2.255E-03 | 3.787E-02 | TP53, HIF1A, TLR2 |
09150 Organismal Systems | 09152 Endocrine system | hsa04923 | Regulation of lipolysis in adipocytes | 2.397E-03 | 3.787E-02 | FABP4, TSHR |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 3.214E-03 | 3.850E-02 | ALDH1A1, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.411E-03 | 3.850E-02 | TP53, HIF1A |
09160 Human Diseases | 09167 Infectious diseases | hsa05160 | Hepatitis C | 1.285E-02 | 8.654E-02 | PPARA, TP53 |
09160 Human Diseases | 09167 Infectious diseases | hsa05162 | Measles | 1.341E-02 | 8.654E-02 | TP53, TLR2 |
09160 Human Diseases | 09167 Infectious diseases | hsa05161 | Hepatitis B | 1.534E-02 | 8.654E-02 | TP53, TLR2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure | Diagnostic test to differentiate primary and secondary hypothyroidism | W88 | TSHR; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Cancer | C00-C96 | TP53; |
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR; |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; |